Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
about
Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemiaDendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytesTrial watch: Dendritic cell-based anticancer therapyUsing magnetic resonance imaging to evaluate dendritic cell-based vaccinationThe Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanismInterleukin-12 secreted by mature dendritic cells mediates activation of NK cell functionAntigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.Tumor antigens and tumor vaccines: peptides as immunogens.DCVax®-L--developed by Northwest BiotherapeuticsDetection of HLA class II-dependent T helper antigen using antigen phage display.A novel, rapid strategy to form dendritomas from human dendritic cells and hepatocellular carcinoma cell line HCCLM3 cells using mature dendritic cells derived from human peripheral blood CD14+ monocytes within 48 hours of in vitro culture.Bone marrow-derived dendritic cells under influence of experimental breast cancer and physical activity.Advances in cancer vaccine development.Immune and gene therapy for melanoma, and the immunobiology of melanoma.CD40-activated B cells induce anti-tumor immunity in vivo.Role of dendritic cells in the induction and maintenance of autoimmune diseases.The role of B7 costimulation in T-cell immunity.Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinomaMurine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivoCell-based vaccines for the stimulation of immunity to metastatic cancers.Dendritic cells efficiently induce protective antiviral immunity.Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease.New technologies toward dendritic cell-based cancer immunotherapies.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model.An overview of cancer immunotherapy.Feeding dendritic cells with tumor antigens: self-service buffet or à la carte?Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.Dendritic cells and immunotherapy for malignant disease.Biologic and therapeutic role of HER2 in cancer.Dendritic cells for specific cancer immunotherapy.Dendritic cell vaccination for cancer therapy.Progress on new vaccine strategies for the immunotherapy and prevention of cancer.T-cell-directed cancer vaccines: the melanoma model.Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer ImmunotherapyStrategies for designing and optimizing new generation vaccines.Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
P2860
Q24800882-DA633020-2BE9-472B-A737-9D41AAFCDA2CQ24806024-B5E1C112-87E0-4773-BA25-6E93D1977024Q27024047-8ACAB135-C98A-4079-9D9D-D3AFC7B9D444Q27316977-516B1122-0883-4FDB-8B69-F0434804B0DEQ28346519-625D57A4-21D3-44F9-996B-8F48A0A83527Q28569690-D5305210-4E31-4296-A297-379647AB485FQ30310231-1639CD46-5C5E-49C0-AF0A-DECB3BE9ACA3Q30311891-EF9A71E7-B7F6-4405-AE27-F75881BBA801Q30469630-A6E5012A-58EA-4DDC-91FA-BA4C1E6D0E29Q30875456-2C479E6E-4A8D-4BCF-AB86-4988804E9921Q31037295-79E7E5E0-D847-450D-A845-217786D6F68AQ33208820-58349250-D1B8-42E1-AFB7-23751590C3DCQ33597987-0EF9C790-A95C-44EA-8FAF-7CF8571AC7C7Q33603404-D1C08B0D-2D2F-411A-9590-48E3BB3282C1Q33706946-3F82703D-CA09-4005-9436-D9EAF2FD0BB9Q33709425-30A4CC9C-CB3E-48A2-95C8-3014A2212757Q33713274-77B4C51B-CD77-447F-8DA2-611F6BBB7C60Q33717482-D4FE9670-C204-41E8-895C-2129C6CEBC57Q33738279-90E65609-4954-4CE4-A171-07616FB3A96FQ33765923-6C244667-7E57-46D2-801D-329084152B52Q33776134-5F1FB06B-5C7B-4BBA-A0B4-E521BAD8FEC4Q33782672-BCE03F3C-E10F-474F-A7E7-E5BD166D4202Q33805849-20922175-E322-4E82-A61F-7E7CD3E5FA7FQ33817903-84AD910D-F9B7-4B57-83FB-F961FEBE0D56Q33825567-878C4C73-1706-4510-ABC6-F1B77F1C3F6EQ33855405-07EBD729-CF5C-4D19-AC5E-C6597395F5DFQ33892712-C51FEE2C-F501-4808-8CE0-B28A50D2CCACQ33940388-3722E25B-B0F7-4D53-AB8B-63BE0ED99C34Q33986125-8CA52519-81C0-4C42-817A-56047F925692Q34009362-B2C6BD01-73D1-4AA7-8F96-B8812A814929Q34075717-E10D1977-2444-4C0B-B61D-DC2AA61DDAC5Q34216506-C5D35F63-9FC2-4E28-8EFA-C57CA6137435Q34267775-709CB4F6-7122-45A7-B1F9-535F2714F016Q34280913-AA6C920D-9E68-4C41-A1AC-0FBAB1112700Q34293614-2C9DDA67-7F22-4F17-8EF5-C953DBF353DFQ34328457-8CAB9470-B15A-4DF4-BE27-E4075E56447EQ34452071-F48C3904-9F77-4534-8111-0F0D82EBCE0AQ34521036-D51431BA-7EF0-44AB-8F9B-21ADA5EAF267Q34572198-79C965D2-9437-422F-B4F9-8DD59079018AQ34646946-C712A997-534F-42C8-B4B0-34EE6217E375
P2860
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Therapy of murine tumors with ...... r cell 1-associated cytokines.
@ast
Therapy of murine tumors with ...... r cell 1-associated cytokines.
@en
type
label
Therapy of murine tumors with ...... r cell 1-associated cytokines.
@ast
Therapy of murine tumors with ...... r cell 1-associated cytokines.
@en
prefLabel
Therapy of murine tumors with ...... r cell 1-associated cytokines.
@ast
Therapy of murine tumors with ...... r cell 1-associated cytokines.
@en
P2093
P2860
P356
P1476
Therapy of murine tumors with ...... r cell 1-associated cytokines.
@en
P2093
J I Mayordomo
M R Clarke
T Tjandrawan
W J Storkus
P2860
P356
10.1084/JEM.183.1.87
P407
P577
1996-01-01T00:00:00Z